Radiation Dosimetry of the 18 kDa Translocator Protein Ligand [18F]PBR111 in Humans

\[18F\]PBR111 is a radiotracer produced at University Hospital of Geneva in a radiopharmaceutical GMP facility. The drug product is provided as sterile solution for intravenous injection in a glass vial containing 10 mL (max) of formulated product, the maximal applicable dose being 200 MBq.

\[18F\]PBR111 will be administered once, intravenously in the antecubital fossa at a dose of 200 MBq

Upon administration of the radiotracer, a 120-minute PET/CT scan will be initiated.

to establish the exposure of the organs/tissues to a standard radioactive dose (200 MBq) of \[18F\]PBR111